Genetic and genomic studies in the hypertension: An actualization;Genética y genómica de la hipertensión arterial: Una actualización

Archivos de Cardiologia de Mexico

Volumn 81, Issue 3, 2011, Pages 240-250

  Ramírez Bello, Julián ^a   Pérez Méndez, Oscar ^b   Ramírez Fuentes, Silvestre ^b   Carrillo Sánchez, Silvia ^b   Vargas Alarcón, Gilberto ^b   Fragoso, José Manuel ^b  

^a INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^b INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

Arterial hypertension; Genetic; Genomic; Mexico

Indexed keywords

BLINDNESS; CARDIOVASCULAR RISK; CAUSE OF DEATH; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENOMICS; HEART FAILURE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERTENSION; KIDNEY FAILURE; MORBIDITY; PREVALENCE; REVIEW; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETICS; PEDIGREE; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC ASSOCIATION STUDIES; GENETIC LINKAGE; GENOMICS; HUMANS; HYPERTENSION; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84859553712     PISSN: 14059940     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Vargas-Alarcón G. Physiopathogenesis of hypertension. Arch Cardiol Mex 2006;76:157-160.
2. Mongeau JG. Heredity and blood pressure. Semin Nephrol 1989;9:208-216.
3. Dubey RK, Oparil S, Imthurn B, et al. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
4. Luft FC. Hypertension as a complex genetic trait. Semin Nephrol 2002;22:115-126.
5. The World Health Organization. The World Health Report 2002- Reducing Risks, Promoting Healthy Life. WHO, 2002.
6. Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
7. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006.
8. Whelton PK, He J, Appel LJ, et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002;288:1882-1888.
9. Titze J, Ritz E. Salt and its effect on blood pressure and target organ damage: new pieces in an old puzzle. J Nephrol 2009;22:177-189.
10. Mark AL, Correia M, Morgan DA, et al. Obesity-Induced hypertension. New concepts from the emerging biology of obesity. Hypertension 1999;33:537-541.
11. Rafiq S, Anand S, Roberts R. Genome-wide association studies of hypertension: Have they been fruitful? J Cardiovasc Transl Res 2010;3:189-196.
12. O'Shaughnessy KM. The genetics of essential hypertension. Br J Clin Pharmacol 2001;51:5-11.
13. McIlhany ML, Shaffer JW, Hines EA Jr. The heritability of blood pressure. An investigation of 200 twin pairs using the cold pressure test. J Hopkins Med J 1975;136:57-74.
14. Ruppert V, Maisch B. Genetic of human hypertension. Herz 2003;28:655-662.
15. Mathew C. Science, medicine, and the future: Posgenomic technologies; hunting the genes for common disorders. BMJ 2001;322:1031-1034.
16. Litt M, Luty JA. A hypervariable microsatellite revelated by in vitro amplification of a dinucleotide repeat within the cardiac muscle actin gene. Am J Hum Genet 1989;44:397-401.
17. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000;405:847-856.
18. Ronaghi M, Langaee T. Single nucleotide polymorphism: discovery, detection and analysis. Perzonalized Medicine 2005;2:111-125.
19. Mayeux R. Mapping the new frontier: complex genetic disorders. J Clin Invest 2005;115:1404-1407.
20. Elahi E, Kumm J, Ronaghi M. Global genetic analysis. J Biochem Mol Biol 2004;37:11-27.
21. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992;71:169-180.
22. Krushkal J, Ferrell R, Mockrin SC. Genome-wide linkage analysis of systollic blood pressure using highly discordant sibling. Circulation 1999;99:1407-1410.
23. Ledy D, DeStefano AL, Larson MG, et al. Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Hear Stude. Hypertension 2000;36:477-483.
24. Daly AK. Candidate gene case-control studies. Pharmacogenomics 2003;4:127-139.
25. McCarthy MI, Abecasis GA, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainly and challenges. Nat Rev Genet 2008;9:356-69.
26. Shi J, Wang Y, Huang W. Development and application of genotyping technologies. Sci China C Life Sci 2009;52:17-23.
27. Kirov G, Nicolov I, Georgieva L, et al. Pooled DNA genotyping of Affymetrix SNP genotyping arrays. BMC Genomics 2006;7:27.
28. Morton NE. Linkage disequilibrium maps and association mapping. J Clin Invest 2005;115:1425-1430.
29. Redon R, Ishikawa S, Fitch KR, et al. Global variation in copy number in the human genome. Nature 2006;444:444-454.
30. Iafrate AJ, Feuk L, Rivera MN, et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-951.
31. Tuzum E, Sharp AJ, Bailey JA, et al. Fine-scale structural variation of the human genome. Nat Genet 2005;37:727-732.
32. Feuk L, Carson AR, Scherer SW. Structural variation in the human genome. Nat Rev Genet 2006;7:85-97.
33. McKinney C, Mirriman ME, Chapman PT, et al. Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis 2008;67:409-413.
34. Aitman TJ, Dong R, Vyse TJ, et al. Copy number polymorphism in Fcgr3 predisposes to glomeronephritis in rats and humans. Nature 2006;439:851-855.
35. Baca V, Orozco L. La genética de las enfermedades complejas en: La frontera: Genética Molecular de la enfermedad. Ed. Instituto Politécnico Nacional. 2004;pp:77-91.
36. De Gobbi M, Viprakasit V, Hughes JR, et al. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 2006;312:1215-1217.
37. Knight JC. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulatory. Clin Sci (Lond) 2003;104:493-501.
38. Knight JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005;83:97-109.
39. Hunt R, Sauna ZE, Ambudkar SV, et al. Silent (Synonymous) SNPs: Should We Care About Them? Methods Mol Biol 2009;578:23-39.
40. Zee RY, Lou YK, Griffiths LR, et al. Association of a polymorphism of the angiotensin-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 1992;184:9-15.
41. Thammem F, Voruganti VS, He X, et al. Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans. Hum Genet 2008;124:557-559.
42. Kunz R, Kreutz R, Beige J, et al. Association between the angiotensinogen 235T-variant and essential hypertension in whites: A systematic review and methodological appraisal. Hypertension 1997;30:1331-1337.
43. Lalouel JM, Rodrwasser A. Genetic susceptibility to essential hypertension: insight from angiotensinogen. Hypertension 2007;49:597-603.
44. Thiel B, Weder AB. Genes for essential hypertension: hype, help, or hope? J Clin Hypertens (Greenwich) 2000;2:187-193.
45. Sethi AA, Nordestgaar BG, Tybjaerg-Hansen A. Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler Thromb Vasc Biol 2003;23:1269-1275.
46. Izawa H, Yamada Y, Okada T, et al. Prediction of genetic risk for hypertension. Hypertension 2003;41:1035-1040.
47. Mondry A, Loh M, Liu P, et al. Polymorphisms of the insertion/ deletion ACE and M235T AGT genes and hypertension: surprising new findings and meta-analysis of data. BMC nephrol 2005;6:1.
48. Newhouse SJ, Wallace C, Dobson R, et al. Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British genetics of hypertension study. Hum Mol Genet 2005;14:1805-1814.
49. Tobin MD, Releigh SM, Newhouse S, et al. Association of WNK1 gene polymorphism and haplotypes with ambulatory blood pressure in the general population. Circulation 2005;112:3423-3429.
50. Deng AY. Genetic basis of polygenic hypertension. Hum Mol Genet 2007;2:195-202.
51. Pereira TV, Nunes AC, Rudnicki M, et al. Meta-analysis of association of 4 angiotensinogen polymorphisms with essential hypertension: a role beyond M235T? Hypertension 2008;51:778-783.
52. Newhouse S, Farrall M, Wallace C, et al. Polymorphisms in the WNK1 Gene are Associated with Blood Pressure Variation and Urinary Potassium Excretion. Plos One 2009;4:e5003.
53. Niu W, Qi Y, Qian Y, et al. The relationship between apolipoprotein E ε2/ε3/ε4 polymorphism and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res 2009;32:1060-1066.
54. Ying CQ, Wang YH, Wu ZH, et al. Association of the renin gene polymorphisms and the haplotypes with essential hypertension in the Mongolian population. Clin Exp Hypertens 2010;32:293-300.
55. Niu W, Wu S, Zhang Y, et al. Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population. J Hypertens 2010;28:1854-1861.
56. Ong KL, Li M, Tso AW, et al. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong kong Chinese. Eur J Endocrinol 2010;163:251-257.
57. Wang JL, Xue Li, Hao PP, et al. Angiotensin II type 1 receptor gene A1166C polymorphism and essential hypertension in Chinese: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2010;11:127-135.
58. Li N, Luo W, Zhang J, et al. Association of genetic variations in the FURIN gene with hypertension. BMC Med Genet 2010;11:124.
59. Niu W, Qi Y, Gao P, et al. A meta-analysis of the bradykinin B2 receptor gene -58C/T polymorphism with hypertension. Clin Chim Acta 2010;411:324-328.
60. Niu WQ, Zhang Y, Ji KD, et al. Lack of association bertween α-adducin G460W polymorphism and hypertension: evidence from a case-control study and a meta-analysis. J Hum Hypertens 2010;24:467-474.
61. Coto E, Tavira B, Marín R, et al. Functional polymorphism in the CYP3A4, CYP3A5, and CYP21A2 genes in the risk for hypertension in pregnancy. Biochem Biophys Res Commun 2010;397:576-579.
62. Niu WQ, Qi Y. Meta-based association of the lipoprotein lipase gene S447X variant with hypertension and blood pressure variation. J Hum Hypertens 2010 Online.
63. Palmirotta R, Ferroni P, Ludovici G, et al. VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension. Clin Biochem 2010 Online.
64. Niu W, Qi Y, Gao P, et al. Association between angiotensin converting enzime G2350A polymorphism and hypertension risk: a meta-analysis. J Renin Angiotensin Aldosteron Syst 2010 Online.
65. Souza-Costa DC, Belo VA, Silva PS, et al. eNOS haplotype associated with hypertension in obese children and adolecents. Int J Obes (London) 2011;35:387-92.
66. Niu W, Qi Y. Association of angiotensin II type I receptor gene +1166A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects. Hypertens Res 2010 Online.
67. Nielsen SJ, Jeppesen J, Torp-Pedersen C, et al. Tyrosine hydroxylase polymorphism (C-824T) and hypertension: a population-based study. Am J Hypertens 2010;23:1306-11.
68. Wang B, Zhang G, Ouyang J, et al. Association of DNA polymorphism within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosteron-producing adenomas. Urology 2010;76:1018.e1-7.
69. O'Shaughnessy KM. Dissecting complex traits: recent advances in hypertension genomics. Genome Med 2009;1:43.
70. Levy D, Larson M, Benjamin E, et al. Framinghan heart study 100K project: genome-wide associations for blood pressure and arterial stiffness. BMC Med Genet 2007;8:53.
71. The Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-678.
72. Ehret GB. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010;12:17-25.
73. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336.
74. Kato N, Miyata T, Tabara Y, et al. High-density association study and nomination of susceptibility genes for hypertension in the Japanese National Project. Hum Mol Genet 2008;17:617-627.
75. Sabatti C, Service SK, Hartikainen AL, et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009;41:35-46
76. Wang Y, O'Connell JR, McArdle PF, et al. From the cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proc Natl Acad Sci USA 2009;106:226-231.
77. Org E, Eyheramend S, Peeter J, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European population. Hum Mol Genet 2009;18:2288-2296.
78. Yang HC, Liang YJ, Wu YL, et al. Genome-wide association study of young-onset hypertension in the Han Chinese population of Taiwan. Plos One 2009;4:55459.
79. Cho YS, Go MJ, Kim YJ, et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing quantitative traits. Nat Genet 2009;41:527-534.
80. Adeyemo A, Gerry N, Chen G, et al. A genome-wide association study of hypertension and blood pressure in african americans. Plos One 2009:5:e1000564.
81. Newton-Cheh C, Johnson T, Gateva V, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 2009;41:666-76.
82. Levy D, Ehret GB, Rice K, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet 2009;41:677-687.
83. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat Rev Cancer 2006;6:947-960
84. Fitau J, Boulday G, Coulon F, et al. The adaptor molecule Link negatively regulates tumor necrosis factor-alpha-dependet VCAM-1 expression in endothelial cells throgh inhibition of the ERK1 and -2 phatways. J Biol Chem 2006;281:20148-20159.
85. Velazquez L, Cheng AM, Fleming HE, et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Link-deficient mice. J Exp Med 2002;195:1599-1611.
86. Vatner SF. FGF induces hypertrophy and angiogenesis in hipernating myocardium. Circ Res 2005;96:705-707.
87. Takeuchi F, Isono M, Katsuya T, et al. Blood pressure and hypertension are associated with 7 loci in the Japanese population. Circulation 2010;121:2302-2309.
88. Niu W, Zhang Y, Ji K, et al. Confirmation of top polymorphism in hypertension genome wide association study among Han Chinese. Clin Chim Acta 2010;411:1491-1495.
89. Tabara Y, Kohara K, Kita Y, et al. Common variants in the ATP2B1 gene are associated with susceptibility to hypertension: the Japanese Millennium Genome Project. Hypertension 2010;56:973-980.
90. Vargas-Alarcón G. Polimorfismos genéticos en enfermedades cardiovasculares. La experiencia en el Instituto Nacional de Cardiología Ignacio Chávez. Arch Cardiol Mex 2007;77:88-93.
91. Thammem F, Voruganti VS, He X, et al. Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans. Hum Genet 2008;124:557-559.
92. Nath SD, He X, Voruganti VS, et al. The 27-bp repeat polymorphism in intron 4 (27 bp-VNTR) of endothelial nitric oxide synthase (eNOS) gene is associated with albumin to creatinine ratio in Mexican Americans. Mol Cell Biochem 2009;331:201-205.
93. Isordia-Salas I, Leaños-Miranda A, Borrayo-Sánchez G. The Glu298Asp polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population. Clin Chim Acta 2010;411:78.
94. Isordia-Salas I, Trejo-Aguilar A, Valadés-Mejía MG, et al. C677T polymorphism of 5, 10 MTHFR gene in young Mexican subjects with ST-elevation myocardial infarction. Arch Med Res 2010;41:246-250.
95. Meaney E. Molecular aspect of systemic arterial hypertension. Arch Cardiol Mex 2006;76:170-175.
96. Turner ST, Shawartz GL, Chapman AB, et al. Antihypertensive pharmacogenetics: getting the right drug into the right patient. J Hypertens 2001;19:1-11.
97. Johnson AD, Gong Y, Wang D, et al. Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension. Clin Pharmacol Ther 2009;85:36-44.